When Dr Moro presented data at this year's ISOBM, he had now taken recaf into new territory. Shareholders and investors have to realize what Dr Moro has accomplished. He has eliminated all false positives, and I simply call it "juiced" results from 40-50% accuracy in detecting cancer to over 90%. That is what you call raising the bar substantially. I have to believe Inverness and Abbott have to be giddy to know they have locked in two of only three licenses available. There is no way they knew or Dr Moro for that matter how well recaf worked when combined with current markers. IMO the IPO will be a slam dunk, and the future for shareholders will turn out to be one of the most lucrative investments for those that have had the fortitude to hold and trust Dr Moro. In a few short weeks we will be turning the corner into a new year and IMO as long as management delivers and does their part correctly, the long wait will finally pay off for all. Everyone benefits by a successful launch for recaf......Investors, management, our licensees, and all of mankind. I am just waiting for some more good news.

Good luck longs.